Global Oral Rotavirus Vaccine Market Size By Product (Rotarix, RotaTeq), By Application (Hospital, Vaccination Station), By Age Group (Pediatric), By Geographic Scope And Forecast

Oral Rotavirus Vaccine Market Size And Forecast

Oral Rotavirus Vaccine Market size is growing at a good pace over the last few years and is expected to grow at a CAGR of 12.8% over the forecasted period i.e 2020 to 2027.

The main growth factor for the Oral Rotavirus Vaccine Market is the cost-effectiveness and efficiency of administration of Oral Rotavirus Vaccines by removing the need for disposable needles and making vaccines more appropriate for mass vaccination programs. The Global Oral Rotavirus Vaccine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Oral Rotavirus Vaccine Market Definition

Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. The rotavirus vaccine is used to safeguard young children from rotavirus infections, which cause severe diarrhea. Major diarrhea, fever, and stomach pain, vomiting is all manifestation of rotavirus infection, which can lead to disease. Rotavirus vaccine is given by mouth in two or three doses beginning at about the age of six weeks. The Oral Rotavirus Vaccine Market is driven by its safety profile, which includes use in HIV-AIDS patients, a rising number of immune-compromised individuals, population growth, an aging population, and live births, among other factors.

Rotavirus is a Reoviridae virus with a double-stranded RNA genome that is transmitted through the feces-oral pathway. It causes gastroenteritis by infecting the cell lining of the small intestine. Moreover, good hygiene like handwashing and cleanliness are important but are not enough to control the spread of the disease. Therefore, the rotavirus vaccine is the best way to protect your child against rotavirus disease. Also, most children (about 9 out of 10) who get the vaccine will be protected from severe rotavirus disease.

About 7 out of 10 children will be protected from rotavirus disease of any severity. Therefore, the rotavirus vaccine should be included in national routine vaccination programs, according to the World Health Organization (WHO). In the developing world, vaccines are responsible for preventing 15 to 34 percent of extreme diarrhea, and in the developed world, vaccines are responsible for preventing 37 to 96 percent of severe diarrhea. Also, according to the World Health Organization (WHO) in Mexico, the vaccine has resulted in a 50 percent reduction in diarrheal deaths in children under the age of five.

Global Oral Rotavirus Vaccine Market Overview

The main growth factor for the Oral Rotavirus Vaccine Market is the cost-effectiveness and efficiency of administration of Oral Rotavirus Vaccines by removing the need for disposable needles and making vaccines more appropriate for mass vaccination programs. The rising prevalence of rotavirus in children, as well as increased awareness of the rotavirus vaccine, has fueled demand for Oral Rotavirus vaccines. However, factors such as the growing geriatric population, advancements in Oral Rotavirus Vaccine, and increased government funding are expected to boost the market growth. However, delays in the production process and the risk of vaccine contamination if not properly stored are two factors that may limit the market’s development.

The effect of several social, political, and economic factors, as well as current market dynamics, on the Global Oral Rotavirus Vaccine Market development, has been factored into these market estimates. Risks such as immune reactions, intussusception in infants, low healthcare expenditure in developing regions, cleanliness initiatives by NGOs, and health awareness building to eliminate the prevalence of this virus, among others, are market constraints. On the contrary, side effects are rare, usually mild, and may include fussiness, diarrhea, and vomiting.

Therefore, some studies have shown a small growth in cases of intussusception within a week after the first or second dose of the rotavirus vaccine. Intussusception is a type of bowel blockage that is treated in a hospital. Most children recover from rotavirus with no long-term health effects. Moreover, to protect against rotavirus disease, the CDC suggests that infants get a rotavirus vaccine. Furthermore, the rotavirus vaccine is extremely safe and effective at protecting children from rotavirus infection.

Global Oral Rotavirus Vaccine Market Segmentation Analysis

The Global Oral Rotavirus Vaccine Market is Segmented on the basis of Product, Application, Age Group, And Geography.

Oral Rotavirus Vaccine Market, By Product

• Rotarix• RotaTeq• Rotavac• Rotavin-M1• Lanzhou Lamb

Based on Product, the market is segmented into Rotarix, RotaTeq, Rotavac, Rotavin-M1, and Lanzhou Lamb. The Rotarix segment holds a big market share. Rotarix is indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series in infants and children.

Oral Rotavirus Vaccine Market, By Application

• Hospital• Vaccination Station• Others

Based on Application, the market is segmented into Hospital, Vaccination Station, and Others. Vaccination Station is a low-cost mobile vaccination clinic that visits predetermined locations on a monthly basis.

Oral Rotavirus Vaccine Market, By Age Group

• Pediatric• Other

Based on Age Group, the market is segmented into the Pediatric age group and Other. The Pediatric segment holds the big market share. Therefore, the first dose of the rotavirus vaccine should be given before a child is 15 weeks of age. Children should receive all doses of the rotavirus vaccine before they turn 8 months of age.

Oral Rotavirus Vaccine Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Oral Rotavirus Vaccine is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia Pacific region is expected to witness the highest CAGR during the forecast period. This is primarily due to the rise in rotavirus infections in these countries.

Key Players

The “Global Oral Rotavirus Vaccine Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as China National Biotech Group, Hualan Biological Engineering, Sinovac Biotech, Bharat Biotech, GSK, Sanofi-Pasteur, MERCK & CO. INC., CSL Biotherapies, LG Life Sciences, and Cru Cell.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In 2021, Sanofi had announced to acquire Translate Bio, which advances the deployment of mRNA technology across vaccines, and therapeutics development.

• In 2019, Bharat Biotech had announced to launch of a new variant of its rotavirus vaccine, Rotavac 5D, a smaller dosage form of its earlier oral immunization shot that can be stored at a relatively higher temperature.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.